Report error Found 283 Enz. Inhib. hit(s) with Target = 'Histone-lysine N-methyltransferase EZH2 [A677G]'
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G]/Polycomb protein EED/Polycomb protein SUZ12(Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.210nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (SBMRI, San Diego, CA) NIH Molecular Libraries Screen...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G]/Polycomb protein EED/Polycomb protein SUZ12(Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.230nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (SBMRI, San Diego, CA) NIH Molecular Libraries Screen...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G]/Polycomb protein EED/Polycomb protein SUZ12(Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.240nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (SBMRI, San Diego, CA) NIH Molecular Libraries Screen...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [A677G]/Polycomb protein EED/Polycomb protein SUZ12(Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.260nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (San Diego, CA) NIH Molecular Libraries Screening Cen...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G]/Polycomb protein EED/Polycomb protein SUZ12(Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.280nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (San Diego, CA) NIH Molecular Libraries Screening Cen...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G]/Polycomb protein EED/Polycomb protein SUZ12(Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.310nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (San Diego, CA) NIH Molecular Libraries Screening Cen...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [A677G]/Polycomb protein EED/Polycomb protein SUZ12(Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.330nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (SBMRI, San Diego, CA) NIH Molecular Libraries Screen...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G]/Polycomb protein EED/Polycomb protein SUZ12(Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.340nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (SBMRI, San Diego, CA) NIH Molecular Libraries Screen...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G]/Polycomb protein EED/Polycomb protein SUZ12(Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.340nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (SBMRI, San Diego, CA) NIH Molecular Libraries Screen...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G]/Polycomb protein EED/Polycomb protein SUZ12(Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.350nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (SBMRI, San Diego, CA) NIH Molecular Libraries Screen...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G]/Polycomb protein EED/Polycomb protein SUZ12(Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.360nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (SBMRI, San Diego, CA) NIH Molecular Libraries Screen...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [A677G]/Polycomb protein EED/Polycomb protein SUZ12(Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.360nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (SBMRI, San Diego, CA) NIH Molecular Libraries Screen...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [A677G](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [A677G]/Polycomb protein EED/Polycomb protein SUZ12(Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.370nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (SBMRI, San Diego, CA) NIH Molecular Libraries Screen...More data for this Ligand-Target Pair

















































